Lee, Stephanie J.

Activating mutation in the tyrosine kinase JAK2 in polycythemia vera, essential thrombocythemia, and myeloid metaplasia with myelofibrosis

Levine, R. L., Wadleigh, M., Cools, J., Ebert, B. L., Wernig, G., Huntly, B. J. P., Boggon, T. J., Wlodarska, I., Clark, J. J., Moore, S., et al. (2005) · Cancer Cell

Myeloproliferative Neoplasms: Diagnosis and TreatmentAcute Myeloid Leukemia Research

Cited by 2,993

A Phase 2 Study of Bortezomib in Relapsed, Refractory Myeloma

Richardson, P. G., Barlogie, B., Berenson, J., Singhal, S., Jagannath, S., Irwin, D., Rajkumar, S. V., Srkalovic, G., Alsina, M., Alexanian, R., et al. (2003) · New England Journal of Medicine

Multiple Myeloma Research and TreatmentsBone health and treatments

Cited by 2,632

Prognostic Mutations in Myelodysplastic Syndrome after Stem-Cell Transplantation

Lindsley, R. C., Saber, W., Mar, B. G., Redd, R., Wang, T., Haagenson, M. D., Grauman, P. V., Hu, Z.-H., Spellman, S. R., Lee, S. J., et al. (2017) · New England Journal of Medicine

Acute Myeloid Leukemia ResearchHematopoietic Stem Cell Transplantation

Cited by 776

Recommended screening and preventive practices for long-term survivors after hematopoietic cell transplantation

Majhail, N. S., Rizzo, J. D., Lee, S. J., Aljurf, M., Atsuta, Y., Bonfim, C., Burns, L. J., Chaudhri, N., Davies, S., Okamoto, S., et al. (2012) · Bone Marrow Transplantation

Hematopoietic Stem Cell TransplantationCancer survivorship and care

Cited by 248

ROCK2 inhibition with belumosudil (KD025) for the treatment of chronic graft-versus-host disease

Jagasia, M., Lazaryan, A., Bachier, C. R., Salhotra, A., Weisdorf, D. J., Zoghi, B., Essell, J., Green, L., Schueller, O., Patel, J., et al. (2021) · Journal of Clinical Oncology

Hematopoietic Stem Cell TransplantationImmunodeficiency and Autoimmune Disorders

Cited by 198

Racial and ethnic disparities in hematologic malignancies

Kirtane, K., & Lee, S. J. (2017) · Blood

Global Cancer Incidence and ScreeningHealth disparities and outcomes

Cited by 168

National Institutes of Health Hematopoietic Cell Transplantation Late Effects Initiative: The Patient-Centered Outcomes Working Group Report

Bevans, M., El-Jawahri, A., Tierney, D. K., Wiener, L., Wood, W. A., Hoodin, F., Kent, E. E., Jacobsen, P. B., Lee, S. J., Hsieh, M. M., et al. (2017) · Biology of Blood and Marrow Transplantation

Cancer survivorship and careChildhood Cancer Survivors' Quality of Life

Cited by 166

Resilience, health, and quality of life among long‐term survivors of hematopoietic cell transplantation

Rosenberg, A. R., Syrjala, K. L., Martin, P. J., Flowers, M. E., Carpenter, P. A., Salit, R. B., Baker, K. S., & Lee, S. J. (2015) · Cancer

Cancer survivorship and careChildhood Cancer Survivors' Quality of Life

Cited by 109

Association Between Donor Leukocyte Telomere Length and Survival After Unrelated Allogeneic Hematopoietic Cell Transplantation for Severe Aplastic Anemia

Gadalla, S. M., Wang, T., Haagenson, M., Spellman, S. R., Lee, S. J., Williams, K. M., Wong, J. Y., De Vivo, I., & Savage, S. A. (2015) · JAMA

Hematopoietic Stem Cell TransplantationTelomeres, Telomerase, and Senescence

Cited by 95